R&D

R&D

Research and Development

Stealth-Body as a smart cell

targeting delivery vehicle

CPP-001 (Protein delivery)

CPS-001 (Small molecule delivery)

CPR-001 (Gene delivery)

Smart Cell Targeting

Stealth-Body

CrossPoint’s Stealth-Body shows no binding or activity above background across Fc gamma receptors, far surpassing all previously described modifications.

CrossPoint’s Stealth-Body limits off-target toxicity issues for the development of next-generation antibody therapies.

-Dual targeting

-No Fc effector function

-Natural ligand

-Immune modulation
-No Fc effector function

-RNA regulation

-Tissue & Cell Specificity

Pipeline

Project code, Target, Indication,

Discovery, Preclinical